Ethema Health Corp (GRST)

[Bubae]

Seriously Paul you have been reading my posts for more than two years. Shawn Leon has no qualms about screwing regular shareholders when he needs to. The stock traded at a high of $0.015 in March 2021 then the company dumped 1,316,204,675 new shares between March 31st and the end of 2021 (nine months) taking it into trips for the beginning of 2022. My May post below at the beginning warning traders of this stock to flip it and not hold. Then in 2019 the stock traded as high as $0.07 at the end of June. Then between the end of June 2019 and the end of February 2022 (eight months) they dumped 1,328,566,523 shares taking the price down to $0.0001 where it remained for four months. Conclude however you like but he has a history. I would also assert that traders in this market largely screw themselves by not paying attention to what is in the filings. My May 2021 warning as an example. Bring us now to current events. Not only do we have what is in the filings but Shawn Leon is personally telling us what he is doing.

Then I must conclude that according to you he is a crook screwing us regular shareholders.

Bubae
Re: NorfolkIP post# 30172
Friday, May 14, 2021 1:21:30 PM
Post# 30181 of 50122
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=163811739

Judging by all the support level failures they are clearly converting notes. Get your average down and unload when they promote and this runs again in my opinion. They may be growing, but many here will pay for it with their losses which is typical in the OTC. Play it like a pump and dump and you will be happier in the end. All I have seen in recent months despite the endless promotion on this board is more share value destruction by the company and little communication about operations.

For the quarterly period ended March 31, 2021
https://www.sec.gov/Archives/edgar/data/792935/000172186821000319/f2sgrst10q051921.htm
Page 26
The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 2,262,849,130 and 2,027,085,665 shares of common stock at March 31, 2021 and December 31, 2020, respectively.

For the fiscal year ended: December 31, 2021
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000792935/000190359622000192/sfs10kgrst033022.htm

Page F-28
The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 3,579,053,805 and 2,027,085,665 shares of common stock at December 31, 2021 and December 31, 2020, respectively.


Bubae
Re: None
Monday, June 17, 2024 4:10:08 PM
Post# 50074 of 50221
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174613997&txt2find=billion%2Beight

That over the top press release reminds me of what they did at the beginning of 2020. Huge press release at the end of December 2019 boasting about a letter of intent to purchase a wildly profitable treatment center. Then in January 2020 still boasting about fund raising for this acquisition and stating that they were closing the doors on the only treatment center they had in operation. During the first eight weeks of 2020 they also dumped 1.3 billion new shares taking the price down to $0.0001 where it stayed for four months. They sold conversions as low as $0.00006 a share during this period. They wouldn't own a share of a treatment center again until the summer of 2021 and they are still trying to purchase it.

For the quarterly period ended June 30, 2019
https://www.sec.gov/Archives/edgar/data/792935/000172186819000418/f2sgrst10q081619.htm
Authorized, issued and outstanding
The Company has authorized 500,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 143,596,452 and 124,300,341 as of June 30, 2019 and December 31, 2018, respectively.


For the fiscal year ended: December 31, 2019
https://www.sec.gov/Archives/edgar/data/792935/000172186820000304/f2sgrst10k070620.htm

Authorized, issued and outstanding
The company has issued and outstanding 155,483,897 and 124,300,341 at December 31, 2019 and 2018, respectively.

For the quarterly period ended March 31, 2020
https://www.sec.gov/Archives/edgar/data/792935/000172186820000426/f2sgrst10q092120.htm

12. Stockholders' deficit
a) Common shares
Authorized, issued and outstanding

Between January 6, 2020 and February 27, 2020, the Company issued 1,316,679,078 shares of common stock in terms of conversion notices received from convertible note holders. The shares issued were issued below par based on the market price of the stock on the date of conversion and were valued at $531,005.